Form 4: Encompass Health Director Christopher R. Reidy Reports Acquisition of Restricted Stock Units

Christopher R. Reidy, a director of Encompass Health Corp, reports acquiring 1,424 shares of restricted stock units on May 1, 2025, according to a Form 4 filing with the SEC.

Summary

• On May 1, 2025, Christopher R. Reidy, a director at Encompass Health Corp, acquired 1,424 shares of Encompass Health Common Stock.
• The acquisition was in the form of restricted stock units granted under the Corporation's 2016 Omnibus Performance Incentive Plan.
• Following the transaction, Reidy directly owns 14,431 shares of Encompass Health Common Stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a standard executive compensation practice. The director increasing their stake in the company is generally viewed favorably.

Positives

• The acquisition of restricted stock units aligns the director's interests with those of the shareholders.
• The grant is part of the company's 2016 Omnibus Performance Incentive Plan, suggesting a structured approach to executive compensation.

Industry Context

This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It provides transparency into the holdings of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder confidence due to the director increasing their stake in the company.

Key Dates

Keywords

Encompass Health, Director, Christopher R. Reidy, Form 4, SEC Filing, Restricted Stock Units, EHC, Beneficial Ownership